相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response
Mohammad A. Sayem et al.
ONCOIMMUNOLOGY (2016)
Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses
Yasuharu Nishimura et al.
CANCER SCIENCE (2015)
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Yoshihiro Yoshitake et al.
CLINICAL CANCER RESEARCH (2015)
Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design
Agnieszka K. Grabowska et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
Yu Sawada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Concurrent interaction of DCs with CD4+ and CD8+ T cells improves secondary CTL expansion: It takes three to tango
Stefanie Hoyer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
T-Cell-Receptor-Dependent Signal Intensity Dominantly Controls CD4+ T Cell Polarization In Vivo
Nicholas van Panhuys et al.
IMMUNITY (2014)
Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients
Yusuke Tomita et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Identification of immunogenic LY6K long peptide encompassing both CD4+ and CD8+ T-cell epitopes and eliciting CD4+ T-cell immunity in patients with malignant disease
Yusuke Tomita et al.
ONCOIMMUNOLOGY (2014)
The application of pH-sensitive polymer-lipids to antigen delivery for cancer immunotherapy
Eiji Yuba et al.
BIOMATERIALS (2013)
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
Erik H. J. G. Aarntzen et al.
CANCER RESEARCH (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor
Yusuke Tomita et al.
CLINICAL CANCER RESEARCH (2013)
Generation of a large number of functional dendritic cells from human monocytes expanded by forced expression of cMYC plus BMI1
Miwa Haruta et al.
HUMAN IMMUNOLOGY (2013)
Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
T. S. Clauditz et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
Koji Kono et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
Else-Marit Inderberg-Suso et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Veronique Corbiere et al.
CANCER RESEARCH (2011)
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells
Yusuke Tomita et al.
CANCER SCIENCE (2011)
THERAPEUTIC EFFECTS OF A FUSOGENIC NEWCASTLE DISEASE VIRUS IN TREATING HEAD AND NECK CANCER
Pingdong Li et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang et al.
BMC BIOINFORMATICS (2010)
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
David F. Schaeffer et al.
BMC CANCER (2010)
CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
Rinke Bos et al.
CANCER RESEARCH (2010)
IMP3 expression is correlated with histologic grade of lung adenocarcinoma
Jennifer J. Findeis-Hosey et al.
HUMAN PATHOLOGY (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Violaine Francois et al.
CANCER RESEARCH (2009)
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
Koji Kono et al.
CANCER SCIENCE (2009)
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The oncofetal protein IMP3 - A novel biomarker for endometrial serous carcinoma
Wenxin Zheng et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
IMP3 predicts aggressive superficial urothelial carcinoma of the bladder
Lioudmila Sitnikova et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL
Michiko Harao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy
Takako Suda et al.
CANCER SCIENCE (2007)
Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA
Koji Teramoto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
T helper lymphocytes rescue CTL from activation-induced cell death
Richard Kennedy et al.
JOURNAL OF IMMUNOLOGY (2006)
RNA-binding IMPs promote cell adhesion and invadopodia formation
J Vikesaa et al.
EMBO JOURNAL (2006)
Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment
H Yamane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer
NA Hammer et al.
REPRODUCTION (2005)
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
BS Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells
K Chamoto et al.
CANCER RESEARCH (2004)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma
T Tatsumi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
In vivo cross-presentation of a soluble protein antigen: Kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes
D Nelson et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
